Highly adaptable smartphone-based monitoring for patients with severe mental illness: Feasibility and usability study

针对重度精神疾病患者的高适应性智能手机监测:可行性和可用性研究

阅读:1

Abstract

OBJECTIVE: Severe mental illness (SMI) requires continuous treatment. Smartphone-based monitoring enables real-time data collection and offers a way of complementing clinical workflows by creating a bridge between patients and providers. Since their needs often differ, collaborative and highly adaptable tools are warranted. The objective of this study was to evaluate the feasibility of the highly adaptable remote-measurement-based care intervention Recovery Cat for patients with SMI. Specifically, we aimed to assess patient adherence and retention rates of the system as well as patients' and providers' perceptions of its usability. METHODS: Forty-nine patients were recruited for the 90-day trial and were provided with Recovery Cat a smartphone app designed to collaboratively set up and monitor clinical symptoms and functional parameters. Data were collected through daily self-reports. Feasibility was assessed by the dropout rate and user engagement, while user-friendliness was evaluated by the System Usability Scale (SUS). RESULTS: 29 participants completed the study. The majority were single, unemployed, diagnosed with an affective disorder, had prior psychiatric treatment, and were in continuous outpatient psychiatric care. EMA data were available for 26 participants. 84.61% (n = 22) had an adherence rate of over 50%. The mean number of days between data entry was 1.48 (sd = 2.02). The SUS indicated a positive user experience with a mean of 82.40 (sd = 11.57). CONCLUSION: The results suggest that highly adaptable smartphone-based monitoring is feasible for patients with SMI. High adherence rates and positive usability scores indicate that this approach holds promise for enhancing mental health care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。